These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8759627)

  • 21. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
    Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ
    J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
    Vogt M; Bajorath J
    Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
    Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
    J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
    Liénard BM; Garau G; Horsfall L; Karsisiotis AI; Damblon C; Lassaux P; Papamicael C; Roberts GC; Galleni M; Dideberg O; Frère JM; Schofield CJ
    Org Biomol Chem; 2008 Jul; 6(13):2282-94. PubMed ID: 18563261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies.
    Faulon JL; Visco DP; Pophale RS
    J Chem Inf Comput Sci; 2003; 43(3):707-20. PubMed ID: 12767129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding diversity in dynamic combinatorial libraries: simultaneous exchange of disulfide and thioester linkages.
    Leclaire J; Vial L; Otto S; Sanders JK
    Chem Commun (Camb); 2005 Apr; (15):1959-61. PubMed ID: 15834471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IcePick: a flexible surface-based system for molecular diversity.
    Mount J; Ruppert J; Welch W; Jain AN
    J Med Chem; 1999 Jan; 42(1):60-6. PubMed ID: 9888833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
    Copeland RA
    Methods Biochem Anal; 2005; 46():1-265. PubMed ID: 16350889
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative molecular field analysis of a series of paclitaxel analogues.
    Zhu Q; Guo Z; Huang N; Wang M; Chu F
    J Med Chem; 1997 Dec; 40(26):4319-28. PubMed ID: 9435901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
    Kulkarni SS; Kulkarni VM
    J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative molecular field analysis of cytotoxic beta-carboline analogs.
    Hou XR; Chen Q; Cao RH; Peng WL; Xu AL
    Acta Pharmacol Sin; 2004 Jul; 25(7):959-65. PubMed ID: 15210072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives.
    Caballero J; Fernández M; Saavedra M; González-Nilo FD
    Bioorg Med Chem; 2008 Jan; 16(2):810-21. PubMed ID: 17964795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible Michael addition of thiols as a new tool for dynamic combinatorial chemistry.
    Shi B; Greaney MF
    Chem Commun (Camb); 2005 Feb; (7):886-8. PubMed ID: 15700070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
    Roy PP; Roy K
    Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.